Resources from the same session
Tumor agnostic development of antibody-drug conjugates
Presenter: Barbara Pistilli
Session: What’s new on antibody-drug conjugates?
Resources:
Slides
Webcast
Optimising the safety of novel antibody-drug conjugates
Presenter: Toshio Shimizu
Session: What’s new on antibody-drug conjugates?
Resources:
Slides
Webcast